Semantic Scholar uses AI to extract papers important to this topic.
The study presents treatment results of 168 patients with non small cell lung cancer in stage IIIB and IV treated… Expand OBJECTIVE
To investigate the activity and clinical efficacy of toremifene plus mitomycin, vindesin and cisplatin regimen (MVP) in… Expand PURPOSE
A prospective Phase I/II dose escalation study was conducted to determine the maximum tolerated dose (MTD) in three… Expand PURPOSE
To compare a regimen of vinorelbine and cisplatin (VC) to the combination of mitomycin, vindesine, and cisplatin (MVP) in… Expand The majority of patients diagnosed with non-small cell lung carcinoma (NSCLC) present with advanced disease and, as such, are… Expand Objective: To explore the change of pathology and the clinical response rate treated by neoadjuvant chemotherapy with MVP regimen… Expand In a prospective randomized study, 287 patients with advanced non-small cell lung cancer (NSCLC) stage IIIb or IV with ECOG… Expand Cisplatin has many toxic effects; emesis, impairment of renal function, myelosuppression, peripheral neuropathy, ototoxicity and… Expand Between August 1985 and June 1986, 49 previously untreated patients with locally advanced or metastatic non-small-cell lung… Expand